Adjuvant Chemotherapy for Stage II Right- and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data

PURPOSE: Survival benefit from adjuvant chemotherapy is established for stage III colon cancer; however, uncertainty exists for stage II patients. Tumor heterogeneity, specifically microsatellite instability (MSI) which is more common in right-sided cancers, may be the reason for this observation. W...

詳細記述

保存先:
書誌詳細
主要な著者: Weiss, Jennifer M., Schumacher, Jessica, Allen, Glenn O., Neuman, Heather, Lange, Erin O’Connor, LoConte, Noelle K., Greenberg, Caprice C., Smith, Maureen A.
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4016118/
https://ncbi.nlm.nih.gov/pubmed/24643898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-3631-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料